Andrew Willeford

Title(s)Assistant Clinical Professor, School of Pharmacy and Pharmaceutical Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

Collapse Bibliographic 
Collapse Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Outcomes of a multidisciplinary approach to management of mavacamten in obstructive hypertrophic cardiomyopathy. Am J Health Syst Pharm. 2024 Nov 29. Jensen H, Yousif Z, Huynh T, Kraushaar M, Reed M, Boarman T, Silva Enciso J, Willeford A. PMID: 39611751.
    View in: PubMed   Mentions:    Fields:    
  2. Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence. Curr Opin Cardiol. 2024 05 01; 39(3):178-187. Gale SE, Willeford A, Sandquist K, Watson K. PMID: 38353280.
    View in: PubMed   Mentions:    Fields:    Translation:Humans
  3. Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy. JACC Adv. 2023 Oct; 2(8):100622. Zhu M, Reyes KRL, Bilgili G, Siegel RJ, Lee Claggett B, Wong TC, Masri A, Naidu SS, Willeford A, Rader F. PMID: 38938334; PMCID: PMC11198509.
    View in: PubMed   Mentions: 1  
  4. Transitioning disopyramide to mavacamten in obstructive hypertrophic cardiomyopathy: A case series and clinical guide. Pharmacotherapy. 2023 Dec; 43(12):1397-1404. Willeford A, Silva Enciso J. PMID: 37688422.
    View in: PubMed   Mentions: 1     Fields:    Translation:Humans
  5. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus. Ann Pharmacother. 2021 07; 55(7):839-845. Willeford A, Zhu W, Stevens C, Thomas IC. PMID: 33191781; PMCID: PMC8842988.
    View in: PubMed   Mentions: 16     Fields:    Translation:Humans
  6. Methohexital-Induced Seizure in a Patient Undergoing Conscious Sedation. J Emerg Med. 2020 Aug; 59(2):224-226. Willeford A, Trumm N, Bisanz B, Parathasarathy V, Clark RF. PMID: 32565170.
    View in: PubMed   Mentions:    Fields:    Translation:Humans
  7. Emerging Challenges to the Safe and Effective Use of Methadone for Cancer-Related Pain in Paediatric and Adult Patient Populations. Drugs. 2020 Feb; 80(2):115-130. Edmonds KP, Saunders IM, Willeford A, Ajayi TA, Atayee RS. PMID: 31820362.
    View in: PubMed   Mentions: 4     Fields:    Translation:Humans
  8. The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain. J Pain Palliat Care Pharmacother. 2018 Dec; 32(4):248-255. Willeford A, Atayee RS, Winters KD, Mesarwi P. PMID: 31125279.
    View in: PubMed   Mentions: 2     Fields:    Translation:Humans
  9. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling. Circulation. 2018 11 27; 138(22):2530-2544. Suetomi T, Willeford A, Brand CS, Cho Y, Ross RS, Miyamoto S, Brown JH. PMID: 30571348; PMCID: PMC6309790.
    View in: PubMed   Mentions: 140     Fields:    Translation:AnimalsCells
  10. CaMKIIδ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis. JCI Insight. 2018 06 21; 3(12). Willeford A, Suetomi T, Nickle A, Hoffman HM, Miyamoto S, Heller Brown J. PMID: 29925681; PMCID: PMC6124412.
    View in: PubMed   Mentions: 60     Fields:    Translation:AnimalsCells
  11. Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr Comp Physiol. 2018 06 01; 314(6):R834-R847. Crotty Alexander LE, Drummond CA, Hepokoski M, Mathew D, Moshensky A, Willeford A, Das S, Singh P, Yong Z, Lee JH, Vega K, Du A, Shin J, Javier C, Tian J, Brown JH, Breen EC. PMID: 29384700; PMCID: PMC6032308.
    View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimals
  12. CaMKIIδ mediates β-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic β-adrenergic stimulation. J Mol Cell Cardiol. 2015 Aug; 85:282-91. Grimm M, Ling H, Willeford A, Pereira L, Gray CB, Erickson JR, Sarma S, Respress JL, Wehrens XH, Bers DM, Brown JH. PMID: 26080362; PMCID: PMC4530053.
    View in: PubMed   Mentions: 37     Fields:    Translation:AnimalsCells
Andrew's Networks
Concepts (82)
Derived automatically from this person's publications.
_
Co-Authors (19)
People in Profiles who have published with this person.
_
Similar People (60)
People who share similar concepts with this person.
_
Same Department
Search Department
_